FDA
approval
· 2025-07-18
FDA Approved: OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
Summary
FDA approves the generic fixed-dose combination of olmesartan medoxomil, amlodipine, and hydrochlorothiazide for hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE)